INTRODUCTION
Tumor necrosis factor α (TNFα) is a key proinflammatory cytokine that controls immune and inflammatory responses and regulates cell proliferation and apoptosis (1) (2) (3) (4) . It is produced by many cell types including macrophages, monocytes, lymphocytes, keratinocytes and fibroblasts in response to inflammation or infection. Human diseases such as rheumatoid arthritis and inflammatory bowel disease are associated with inappropriate production of TNFα or sustained activation of TNFα signaling. Therefore, understanding the regulation of TNFα production and signals transmitted by TNFα is necessary for the development of effective treatments for these diseases.
The pleiotropic biological activities of TNFα are mediated by its binding to two different cell surface receptors, the TNF receptor type I (TNFR1) and the TNF receptor type II (TNFR2) (4) . Neither of these receptors possess enzymatic activities. Signals transduced from these receptors are mediated by cytosolic proteins recruited to the receptors, and their intracellular domains share no significant homology suggesting that they may interact with different cellular proteins. Gene knockout experiments confirm that TNFR1 and TNFR2 control different signaling cascades, and that the majority of TNFα signaling events are mediated by TNFR1 (4) .
Binding of TNFα to TNFR1 induces homo-trimerization of the receptors and recruits cytosolic proteins (4) . These proximal events activate multiple downstream pathways, including activation of two transcription factors NF-κB and AP-1 and activation of those pathways that lead to apoptosis. Over the last decade, many of the molecular mechanisms of TNFα signaling have begun to be deciphered through the identification of proteins that are recruited to the TNF receptors. Upon TNFα binding, TRADD is first recruited to TNFR1 and provides a platform for the recruitment of other death domain-containing proteins, such as RIP and FADD (5) (6) (7) (8) .
TRAF2, a member of the TRAF family of proteins that does not contain the death domain, is recruited to TNFR1 via TRADD (9) . TRAF2 is also an adaptor protein of TNFR2 (10) . Given the very low abundance of the endogenous receptors and proteins recruited to the receptors, together with the limits of the protein identification, most of these proteins were identified under the conditions of overexpression utilized in yeast two-hybrid systems or by affinity purification using recombinant proteins. Therefore, little is known about the composition of the endogenous receptor complex.
Activation of NF-κB is one of the major pathways by which TNFα induces the expression of genes involved in immune and inflammatory responses (4) . NF-κB is composed of homo-or hetero-dimers of Rel family members (11) , but the most common form consists of a p50/p65 heterodimer. NF-κB is retained in the cytoplasm by a family of inhibitory proteins known as I-κB proteins. In response to TNFα, the I-κB proteins are phosphorylated by the I-κB kinase (IKK) complex, which contains IKKα, IKKβ, and IKKγ subunits (12) . Phosphorylated I-κB is ubiquitinated and subsequently degraded by the 26S proteasome. NF-κB then translocates to the nucleus where it binds to specific promoter sequences termed κB elements and thereby activates the transcription of NF-κB-driven genes. The IKK complex phosphorylates I-κBα on serine 32 and serine 36. NAK (also known as T2K or TBK1) shares a high degree of homology with IKKα and IKKβ and phosphorylates I-κBα on serine 36 but not serine 32 in vitro (13) (14) (15) .
Thus, it has been proposed to be a member of the IKK family kinases (13) . Nak -/-mice have similar phenotypes to Ikkβ -/-, Ikkγ -/-, and RelA -/-mice, in that they all die at embryonic day 14.5 from massive liver degeneration and apoptosis, which is consistent with this proposal (15) (16) (17) (18) (19) (20) .
Moreover, in Nak -/-mouse embryonic fibroblast cells the transcription of two NF-κB-driven genes, TLR2 and ICAM, are deficient in response to TNFα (15) . Surprisingly, however, in these cells I-κBα degradation and the binding of NF-κB to κB DNA elements are normal. Based on these observations, it has been suggested that NAK may phosphorylate the p65 subunit of NF-κB or act through an unidentified factor to regulate the activation of the NF-κB (13) . Although NAK clearly plays an essential role in the transcription of a subset of TNFα-induced NF-κB driven genes, the precise involvement of NAK in TNFα signaling has remained elusive.
In this study, we explored the composition of the endogenous TNFα-TNFR1 complex using a proteomic approach. Compared to conventional protein identification technologies, the mass spectrometry-based proteomic approach used here has a high sensitivity (down to femtomole detection levels) and can handle a high complexity of samples, which allowed us to identify low abundance proteins from an endogenous complex without purifying each individual protein. We affinity-purified the endogenous TNFα-TNFR receptor complex from U937 cells using Flag-tagged TNFα. Proteins co-purified in the complex were first eluted with Flagpeptides and then with 8M Urea. The eluted proteins were resolved by SDS-PAGE and identified by tandem mass spectrometry. Seven proteins, TRADD, TRAF2, TRAP2, NAK, RasGAP3, and two novel proteins, were identified in the complex. We also demonstrate that recruitment of NAK to TNFR1 is temporally regulated and TNFα-dependent, and that endogenous NAK is required for the TNFα-induced production of the chemokine RANTES.
MATERIALS & METHODS
Cell Culture, antibodies and reagents-U937 and HEK293 cells were obtained from the American Type Culture Collection (ATCC) and cultured in RPMI 1640 (Gibco BRL) and DME (Gibco BRL), respectively, supplemented with 10 % FBS. Anti-TNFR1 antibody (AF225) was Urea. One half of the peptide-eluted proteins or 1/10 of the 8M Urea-eluted proteins was subjected to immunoblot analysis using anti-TRADD or -TRAF2 antibody. The remainders of the samples were separated by SDS-PAGE and visualized by silver staining.
Mass spectrometry and protein identification-Protein bands of interest were manually excised from the gel, reduced, and alkylated with iodoacetamide, and then digested in situ with trypsin using an automated digestion robot (ABIMED, Germany) as previously described (21). The peptide digests were then sequenced using a high-throughput tandem mass spectrometer (ThermoQuest LCQ-DECA, San Jose CA) equipped with a micro-electrospray reversed phase liquid chromatography interface. Data were acquired in automated MS/MS mode using the data acquisition software provided with the LCQ to detect and sequence each peptide as it eluted from the column. The dynamic exclusion and isotope exclusion functions were employed to increase the number of peptide ions that were analyzed. During the LS-MS/MS run, typically >1000 fragmentation spectra were collected from each sample and matched against the nonredundant databases (NCBI) using the Sequest software package (ThermoQuest).
Immunoprecipitation and Western analysis-For immunoprecipitation, 1×10 8 U937 cells were treated with Flag-TNFα at 100 ng/ml for different times, or left untreated. Cell lysates were prepared as described above and subjected to immunoprecipitation using either M2-beads or TNFR1 antibody. Immunoprecipitates were analyzed by immunoblots probed with anti-NAK, -TRADD, or -TRAF2 antibodies. Signals were detected with HRP-conjugated secondary antibody and ECL detection kits (Amersham Pharmacia Biotech). 
Analysis of RANTES production and kinase assays-

RESULTS and DISCUSSION
Purification of the endogenous TNFα-TNFR complex from U937 cells.
Both TNFR1 and TNFR2 are expressed in U937 cells (23) . The binding of TNFα to these receptors triggers their homo-trimerization and the recruitment of cytosolic proteins to the receptor tails. The activated receptors, together with the recruited cytosolic proteins, constitute the TNFα-TNFR complex. In order to understand the composition of the endogenous TNFα-TNFR complex, we treated U937 cells with Flag-tagged TNFα and affinity purified the TNFα-TNFR complex using anti-Flag antibody-conjugated Sepharose beads. TNFα interacts with both receptors, so it was assumed that the TNFα-TNFR complex contains both TNFα-TNFR1 and TNFα-TNFR2, and that proteins associated with either of these receptors would be co-purified.
After purification, the bound complex was eluted with Flag peptides. Proteins eluted from the beads were resolved by SDS-PAGE and visualized by silver staining ( Figure 1A ).
Approximately twelve protein bands were seen in the eluted complex but none of these bands were present in the sample from cells without TNFα stimulation. Thus, these proteins were specifically associated with the TNFα-TNFR complex. As a control, TRADD and TRAF2 were detected by immunoblotting in the eluates from TNFα-treated cells ( Figure 1B) . Therefore, we conclude that the active TNFα-TNFR complex was formed and purified. Identification of proteins co-purified with the receptor complex by mass spectrometry.
To identify the proteins co-purified with the TNFα-TNFR complex, we excised the twelve bands from the silver stained gel in Figure 1A and analyzed them by liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS) after in-gel digestion (see Methods). As expected, TNFα and TRADD were detected in band 12 and band 9, respectively (Table 1) . Surprisingly, we were unable to detect any peptides of TRAF2 at the expected position of band 7 where we had detected it by immunoblotting ( Figure 1B ). Proteins in other bands either could not be determined due to the poor quality of the spectrum or later turned out to be non-specific binding proteins, such as Hsp90 and Hsp71 in band 4 and tropomyosin in band 10.
In a previous study, we found that Flag peptides only elute one tenth of the proteins that bound to the beads (24) . We observed the same phenomenon in the present study as indicated by the low recovery (~10%) of total TRADD on the beads judged by immunoblot analysis (data not shown). This low efficiency of elution was probably due to the multimeric and high affinity interactions between M2-antibodies and trimerized Flag-TNFα-TNFR complex. To increase the amount of proteins eluted from the beads, we treated the beads further with 8M Urea and resolved the eluted proteins by SDS-PAGE. However, 8M Urea also eluted non-specific binding proteins resulting in a pattern that was indistinguishable between the untreated and TNFα-treated samples on the silver stained gel (data not shown). Therefore, we excised the areas that corresponded to the peptide-eluted bands in Figure 1A and then analyzed these bands by mass spectrometry. Proteins identified from the 8M Urea eluates of the untreated sample were proteins that bound non-specifically to the M2-beads. These proteins were subtracted from the total proteins identified in the 8M Urea eluates of the TNFα-treated sample. This resulted in a list of proteins that specifically associated with the TNFα-TNFR complex (Table1).
In the 8M Urea eluates of the TNFα-treated sample, seven peptides of TRAF2 were detected at the band 7 position, and these peptides were totally absent in the control. Peptides of TNFα and TRADD were also detected in the 8M Urea eluates, as were two peptides of TNFR1
and one peptide of TNFR2. The presence of TNFR1, TNFR2, TRADD, and TRAF2 in the 8M
Urea eluates demonstrates that the 8M Urea eluates contained components of both TNFα-TNFR1 and TNFα-TNFR2 complexes.
Five additional proteins were detected in the 8M Urea eluates (Table 1) . Among them, TRAP2, also known as subunit 2 of 26S proteasome, was previously identified in a yeast twohybrid screen for proteins that interact with the intracellular domain of TNFR1 (25, 26) . The detection of TRAP2 in our endogenous TNFα-TNFR1 complex demonstrates that TRAP2
associates with TNFR1 under physiological conditions. Together, these observations suggest a direct interaction of TNFα signaling with the 26S proteosome-mediated protein degradation.
Given the proteasome-mediated degradation of phosphorylated I-κB during the activation of NF-κB, it is conceivable that the regulation of proteosome activity is coupled to the activation of NF-κB during TNFα signaling.
NAK, an IKK family kinase which has been reported to play a critical role in the TNFα-induced activation of NF-κB (13, 15) , was also detected. Thus, there exists a physiological association of NAK with the TNFα-TNFR complex, which confirms and extends the previous observations and unequivocally demonstrates a role for NAK in TNFα signaling under physiological conditions.
We also detected RasGAP3, and two novel proteins KIAA0143 (gi2495710) and FLJ20758 (gi17433930), which we named TRCP1 and TRCP2 (TNF Receptor Complex Protein 1 and 2), respectively. RasGAP3 is an inositol-1,3,4,5-tetrakisphosphate (IP 4 ) binding protein that belongs to the GTPase-activating protein-1 (GAP1) family (27) . RasGAP3 contains a highly conserved RasGAP domain and a pleckstrin-homology domain that localizes it to the plasma membrane (28, 29) . RasGAP3 has not been previously implicated in TNFα signaling; however, MADD, another death domain containing protein that interacts with TNFR1, contains a guanine nucleotide exchange domain of the small GTPase Rab (30, 31) . The association of the TNFR complex with proteins that regulate the activities of small GTPases links TNFα signaling to small GTPases. TRCP1 encodes 885 amino acids and six peptides were identified in the 8M
Urea eluates (Table1). TRCP2 has 689 amino acids and eight peptides were identified (Table 1) .
We did not find any functional domains in TRCP1 and TRCP2. Identification of the specific TNFR receptors that TRCP1, TRCP2, and RasGAP3 interact with, and their functions in TNFα signaling, require further investigation.
NAK is recruited to the TNFR1 receptor in a TNFα-dependent manner and mediates the TNFα-induced production of the chemokine RANTES.
We next tested whether NAK associates with TNFR1 using immunoprecipitation assays with an anti-TNFR1 antibody. As seen in Figure 2 , similar patterns of NAK recruitment were observed in immunoprecipitates using either anti-TNFR1 antibody or anti-Flag (M2) antibody, confirming that NAK was indeed recruited to TNFR1. Moreover, this recruitment was temporally regulated. It peaked between 5 and 10 minutes, later than TRADD and TRAF2, which peaked as early as 2 minutes. NAK has been reported to associate with TRAF2 (13,14) ; therefore, it is likely that TRAF2 mediates the recruitment of NAK to the complex. Importantly, similar to the TNFα-dependent recruitment of TRADD and TRAF2, the recruitment of NAK was also dependent upon TNFα? treatment ( Figure 2B ).
As a key proinflammatory cytokine, TNFα can stimulate the production of various cytokines and chemokines, such as TNFα itself, IL-1, IL-6, IL-8 and RANTES, which mediate and elevate the inflammatory response (32) . RANTES is a chemokine that is able to recruit leukocytes to the sites of inflammation (33) . In response to TNFα stimulation, a high level of RANTES (3000 to 4000 pg/ml) can be produced from synovial fibroblasts and monocytic cells In summary, we have successfully isolated endogenous TNFα-TNFR complexes and identified proteins in these complexes using a mass spectrometry-based proteomic approach.
The TNFα receptors TNFR1 and TNFR2 and seven potential signaling proteins were identified.
Based on our data and previous findings, we conclude that TRADD, TRAF2, TRAP2 and NAK can associate with TNFR1 under physiological conditions, and that TRAF2 and NAK, via association with TRAF2, may form a complex with TNFR2. Our data also indicate that RasGAP3 and the two novel proteins TRCP1 and TRCP2 interact with a TNFα-TNFR complex, although the specific TNFR that these proteins associate with remains unknown. Identification of these molecules in TNFα-TNFR complex furthers our understanding of the molecular events in various TNFα-mediated cellular responses, such as the production of the chemokine RANTES (via NAK), the regulation of proteosome function (via TRAP2), and signaling from small GTPases (via Ras GAP3). Figure 4 A. B.
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